TUBAP4

Across TCGA pan-cancer cohorts, TUBAP4 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of TUBAP4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TUBAP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TUBAP4 is over-expressed in tumor, although a few such as ESCA and LUSC show the opposite, repressed pattern.

KIRC, COAD, and ESCA are the cancer types where TUBAP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TUBAP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.028	.017	6	view →
COAD	All	All	+0.134	.004	4	view →
ESCA	All	II,III,IV	−0.155	.001	2	view →
BRCA	Female	All	+0.075	.020	2	view →
KIRP	All	III,IV	+0.051	.047	2	view →
LUSC	Female	III,IV	−0.224	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

TUBAP4–KIRC

Open the KIRC breakdown →